Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines

AIDS

Volumn 23, Issue 5, 2009, Pages 567-577

  Cassetta, Luca ^a   Fortunato, Orazio ^a   Adduce, Leda ^a   Rizzi, Chiara ^a   Hering, Julia ^b   Rovere Querini, Patrizia ^c   Bianchi, Marco Emilio ^b,d   Alfano, Massimo ^a   Poii, Guido ^a,d,e  

^a AIDS Immunopathogenesis Unit   (Italy)

^b Chromatin Dynamics Unit   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e P2 P3 Laboratories   (Italy)

Author keywords

CC chemokine receptor 5; Chemokines; CXC chemokine receptor 4; Cytokines; High mobility group box 1; HIV; Monocytes macrophages; Receptor for advanced glycation end product; Toll like receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CHEMOTAXIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; KNOCKOUT MOUSE; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; ANTI-HIV AGENTS; CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; HIV INFECTIONS; HIV-1; HMGB1 PROTEIN; HUMANS; MACROPHAGES; MICE; MONOCYTE-MACROPHAGE PRECURSOR CELLS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; U937 CELLS; VIRUS REPLICATION;

EID: 63149181507     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328325a47e     Document Type: Article

References (59)

1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-534.
2. Cassol E, Alfano M, Biswas P, Poli G. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol 2006; 80:1018-1030.
3. Berger EA, Doms RW, Fenyo EM, Korber BT, Liftman DR, Moore JP, et al. A new classification for HIV-1. Nature 1998; 391:240.
4. Philpott SM. HIV-1 coreceptor usage, transmission, and disease progression. Curr HIV Res 2003; 1:21 7-227.
5. Massari FE, Poli G, Schnittman SM, Psallidopoulos MC, Davey V, Fauci AS. In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. J Immunol 1990; 144:4628-4632.
6. Verani A, Pesenti E, Polo S, Tresoldi E, Scarlatti G, Lusso P, et al. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J Immunol 1998; 161:2084-2088.
7. Cullen BR, Greene WC. Regulatory pathways governing HIV-1 replication. Cell 1989; 58:423-426.
8. Alfano M, Poli G. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol Immunol 2005; 42:161-182.
9. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86:5974-5978.
10. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270:1811-1815.
11. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-877.
12. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-1958.
13. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-1148.
14. Schmidtmayerova H, Sherry B, Bukrinsky M. Chemokines and HIV replication. Nature 1996; 382:767.
15. Kinter A, Catanzaro A, Monaco J, Ruiz M, Justement J, Moir S, et al. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc Natl Acad Sci USA 1998; 95:11880-11885.
16. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, Dianzani F. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MlP)-1alpha, MIP-1 beta and RANTES beta-chemokines. AIDS 1998; 12:183-190.
17. Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Opin Genet Dev 2003; 13:170-178.
18. Sessa L, Bianchi ME. The evolution of High Mobility Group Box (HMGB) chromatin proteins in multicellular animals. Gene 2007; 387:133-140.
19. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004; 255:320-331.
20. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5:331-342.
21. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005; 26:381-387.
22. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191-195.
23. Rubartelli A, Cozzolino F, Talio M, Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 1990; 9:1503-1510.
24. Cardella S, Andrei C, Costigliolo S, Poggi A, Zocchi MR, Rubartelli A. Interleukin-18 synthesis and secretion by dendritic cells are modulated by interaction with antigen-specific T cells. J Leukoc Biol 1999; 66:237-241.
25. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997; 11:1421-1431.
26. Youn JH, Shin JS. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006; 177:7889-7897.
27. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003; 22:5551-5560.
28. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8:487-496.
29. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco C, et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007; 110:1970-1981.
30. Chu JJ, Ng ML. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol 2003; 84:3305-3314.
31. Chen G, Chen DZ, Li J, Czura CJ, Tracey KJ, Sama AE, Wang H. Pathogenic role of HMGB1 in SARS? Med Hypotheses 2004; 63:691-695.
32. Sitia G, lannacone M, Muller S, Bianchi ME, Guidotti LG. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol 2006; 81:100-107.
33. Nowak P, Barqasho B, Sonnerborg A. Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection. AIDS 2007; 21:869-871.
34. Naghavi MH, Nowak P, Andersson J, Sonnerborg A, Yang H, Tracey KJ, Vahlne A. Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter-and cell-specific manner. Virology 2003; 314:179-189.
35. Nowak P, Barqasho B, Treutiger CJ, Harris HE, Tracey KJ, Andersson J, Sonnerborg A. HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages. Cytokine 2006; 34:17-23.
36. Thierry S, Gozlan J, Jaulmes A, Boniface R, Nasreddine N, Strauss F, Marechal V. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells. AIDS 2007; 21:283-292.
37. Saidi H, Melki MT, Gougeon ML. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk. PLoS ONE 2008; 3:e3601.
38. Zella D, Barabitskaja O, Burns JM, Romerio F, Dunn DE, Revello MG, et al. Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood 1998; 91:4444-4450.
39. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191:423-434.
40. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5:825-830.
41. Abdel-Latif L, Murray BK, Renberg RL, O'Neill KL, Porter H, Jensen JB, Johnson FB. Cell death in bovine parvovirus-infected embryonic bovine tracheal cells is mediated by necrosis rather than apoptosis. J Gen Virol 2006; 87:2539-2548.
42. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 2004; 173:2280-2287.
43. Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol 2007; 82:1212-1220.
44. Biswas P, Poli G, Orenstein JM, Fauci AS. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? J Virol 1994; 68:2598-2604.
45. Franzoso G, Biswas P, Poli G, Carlson LM, Brown KD, Tomita-Yamaguchi M, et al. A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro ana may impair human immunodeficiency virus replication in these cells. J Exp Med 1994; 180:1445-1456.
46. Alfano M, Poli G. The cytokine network in HIV infection. Curr Mol Med 2002; 2:677-689.
47. Alfano M, Vallanti G, Biswas P, Bovolenta C, Vicenzi E, Mantelli B, et al. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells. J Immunol 2001; 166:1863-1870.
48. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, et al. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galec-tin-3. Diabetes 2005; 54:785-794.
49. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-686.
50. Verani A, Scarlatti G, Comar M, Tresoldi E, Polo S, Giacca M, et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 1997; 185:805-816.
51. Moriuchi H, Moriuchi M, Fauci AS. Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophagetropic human immunodeficiency virus type 1. J Virol 1998; 72:3394-3400.
52. Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 2006; 17:189-201.
53. Telusma G, Datta S, Mihajlov I, Ma W, Li J, Yang H, et al. Dendritic cell activating peptides induce distinct cytokine profiles. Int Immunol 2006; 18:1563-1573.
54. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192:565-570.
55. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 2007; 81:49-58.
56. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 (HMGB1) protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2006; 81:59-66.
57. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
58. Miller CJ, Shattock RJ. Target cells in vaginal HIV transmission. Microbes Infect 2003; 5:59-67.
59. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003; 1:25-34.